These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 34046885)

  • 1. Delta-globin gene expression improves sickle cell disease in a humanised mouse model.
    Porcu S; Simbula M; Marongiu MF; Perra A; Poddie D; Perseu L; Kowalik MA; Littera R; Barella S; Caria CA; Demartis FR; Ristaldi MS
    Br J Haematol; 2021 Jun; 193(6):1228-1237. PubMed ID: 34046885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo activation of the human δ-globin gene: the therapeutic potential in β-thalassemic mice.
    Manchinu MF; Marongiu MF; Poddie D; Casu C; Latini V; Simbula M; Galanello R; Moi P; Cao A; Porcu S; Ristaldi MS
    Haematologica; 2014 Jan; 99(1):76-84. PubMed ID: 23872310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kruppel-like factor 1-GATA1 fusion protein improves the sickle cell disease phenotype in mice both in vitro and in vivo.
    Zhu J; Li H; Aerbajinai W; Kumkhaek C; Pirooznia M; Saxena A; Dagur P; Chin K; Rodgers GP
    Blood; 2022 Nov; 140(21):2276-2289. PubMed ID: 36399071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of delta-globin gene expression by erythroid Krupple-like factor: a potential approach for gene therapy of sickle cell disease.
    Donze D; Jeancake PH; Townes TM
    Blood; 1996 Nov; 88(10):4051-7. PubMed ID: 8916973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study.
    Urbinati F; Campo Fernandez B; Masiuk KE; Poletti V; Hollis RP; Koziol C; Kaufman ML; Brown D; Mavilio F; Kohn DB
    Hum Gene Ther; 2018 Oct; 29(10):1153-1166. PubMed ID: 30198339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta-Globin Gene Expression Is Enhanced
    Manchinu MF; Simbula M; Caria CA; Musu E; Perseu L; Porcu S; Steri M; Poddie D; Frau J; Cocco E; Manunza L; Barella S; Ristaldi MS
    Front Med (Lausanne); 2020; 7():163. PubMed ID: 32528964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus.
    Antoniani C; Meneghini V; Lattanzi A; Felix T; Romano O; Magrin E; Weber L; Pavani G; El Hoss S; Kurita R; Nakamura Y; Cradick TJ; Lundberg AS; Porteus M; Amendola M; El Nemer W; Cavazzana M; Mavilio F; Miccio A
    Blood; 2018 Apr; 131(17):1960-1973. PubMed ID: 29519807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal haemoglobin induction in sickle cell disease.
    Paikari A; Sheehan VA
    Br J Haematol; 2018 Jan; 180(2):189-200. PubMed ID: 29143315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimethyl fumarate increases fetal hemoglobin, provides heme detoxification, and corrects anemia in sickle cell disease.
    Krishnamoorthy S; Pace B; Gupta D; Sturtevant S; Li B; Makala L; Brittain J; Moore N; Vieira BF; Thullen T; Stone I; Li H; Hobbs WE; Light DR
    JCI Insight; 2017 Oct; 2(20):. PubMed ID: 29046485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene replacement therapy for sickle cell disease and other blood disorders.
    Townes TM
    Hematology Am Soc Hematol Educ Program; 2008; ():193-6. PubMed ID: 19074080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroviral transfer of a human beta-globin/delta-globin hybrid gene linked to beta locus control region hypersensitive site 2 aimed at the gene therapy of sickle cell disease.
    Takekoshi KJ; Oh YH; Westerman KW; London IM; Leboulch P
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):3014-8. PubMed ID: 7708766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HbA2-Partinico or delta(A2)Pro-->Thr, a new genetic variation in the delta-globin gene in cis to the beta(+) thal IVS-I-110 G>A, and the heterogeneity of delta-globin alleles in double heterozygotes for beta- and delta-globin gene defects.
    Lacerra G; Scarano C; Musollino G; Testa R; Prezioso R; Caruso DG; Lagona LF; Medulla E; Friscia MG; Gaudiano C; Carestia C
    Ann Hematol; 2010 Feb; 89(2):127-34. PubMed ID: 19609526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta globin gene variations leading to reduction in HbA
    Hariharan P; Colaco S; Colah R; Ghosh K; Nadkarni A
    Int J Lab Hematol; 2016 Dec; 38(6):610-615. PubMed ID: 27461962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of sickle cell disease by homologous recombination in embryonic stem cells.
    Wu LC; Sun CW; Ryan TM; Pawlik KM; Ren J; Townes TM
    Blood; 2006 Aug; 108(4):1183-8. PubMed ID: 16638928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recombinant human hemoglobin with anti-sickling properties greater than fetal hemoglobin.
    Levasseur DN; Ryan TM; Reilly MP; McCune SL; Asakura T; Townes TM
    J Biol Chem; 2004 Jun; 279(26):27518-24. PubMed ID: 15084588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease.
    Liu L; Pertsemlidis A; Ding LH; Story MD; Steinberg MH; Sebastiani P; Hoppe C; Ballas SK; Pace BS
    Exp Biol Med (Maywood); 2016 Apr; 241(7):706-18. PubMed ID: 27022141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HbA2 : biology, clinical relevance and a possible target for ameliorating sickle cell disease.
    Steinberg MH; Rodgers GP
    Br J Haematol; 2015 Sep; 170(6):781-7. PubMed ID: 26104837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases γ-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model.
    Rivers A; Vaitkus K; Ruiz MA; Ibanez V; Jagadeeswaran R; Kouznetsova T; DeSimone J; Lavelle D
    Exp Hematol; 2015 Jul; 43(7):546-53.e1-3. PubMed ID: 25931013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease.
    Menzel S; Thein SL
    Mol Diagn Ther; 2019 Apr; 23(2):235-244. PubMed ID: 30478714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forced chromatin looping raises fetal hemoglobin in adult sickle cells to higher levels than pharmacologic inducers.
    Breda L; Motta I; Lourenco S; Gemmo C; Deng W; Rupon JW; Abdulmalik OY; Manwani D; Blobel GA; Rivella S
    Blood; 2016 Aug; 128(8):1139-43. PubMed ID: 27405777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.